GlassScriptPhysician profile
Travis J Williams
NPI 1417337387
$2,277.16
in general payments reported to CMS, 2019-2025
32 companies · $26.79 in 2025
The $26.79 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $165 · 2021: $336 · 2022: $411 · 2023: $344 · 2024: $881 · 2025: $26.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,251.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $517.54 | 2021-2025 | Qulipta, Ubrelvy |
| Painteq LLC | $271.00 | 2022-2024 | Painteq |
| Piramal Critical Care | $172.75 | 2020-2024 | |
| Allergan, INC. | $167.21 | 2019-2021 | |
| Medtronic, INC. | $110.01 | 2023-2024 | Synchromedii, Vanta Adaptivestim, Intellis Adaptivestim |
| Kite Pharma, INC. | $107.28 | 2024 | Yescarta |
| Ipsen Biopharmaceuticals, INC | $101.28 | 2023-2024 | Dysport |
| Averitas Pharma INC. | $86.63 | 2024 | Qutenza |
| Teva Pharmaceuticals USA, INC. | $85.77 | 2019-2020 | |
| Amgen INC. | $79.33 | 2019-2021 | |
| Astellas Pharma US INC | $66.99 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.03 | 2022-2024 | Relistor |
| Merz Pharmaceuticals, LLC | $55.80 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $44.03 | 2021 | |
| Saluda Medical Americas, INC. | $38.76 | 2023-2024 | Evoke Scs, Evoke |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $28.27 | 2022-2023 | Proclaim |
| Pfizer INC. | $25.04 | 2021-2024 | |
| Dynasplint Systems INC. | $24.72 | 2020 | |
| Radius Health, INC. | $21.37 | 2021 | |
| Lilly USA, LLC | $21.11 | 2021 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Sarepta Therapeutics, INC. | $20.24 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $17.58 | 2022 | |
| Amneal Pharmaceuticals LLC | $17.38 | 2022 | |
| Eisai INC. | $16.64 | 2021 | |
| Lundbeck LLC | $16.01 | 2022 | |
| Biodelivery Sciences International, INC. | $15.61 | 2021 | |
| Si-Bone, INC. | $15.47 | 2022 | |
| Medtronic USA, INC. | $15.18 | 2019 | |
| Boston Scientific Corporation | $15.15 | 2024 | |
| Alnylam Pharmaceuticals INC. | $12.48 | 2022 | |
| Tanabe Pharma America, INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.